Pyott David E I
Director at Alnylam Pharmaceuticals, Inc. (ALNY)
Pyott David E I has filed 28 insider reports with the SEC since July 2021, as director at Alnylam Pharmaceuticals, Inc. (ALNY), director at Tarsus Pharmaceuticals, Inc. (TARS) and director at Pliant Therapeutics, Inc. (PLRX) and at 1 more company. In the last 12 months Pyott David E I sold $1.15M of stock on the open market. The latest filing, on November 12, 2026, reports exercise or conversion of a derivative at Alnylam Pharmaceuticals, Inc. (ALNY).
- Filings
- 28
- Companies
- 4
- Bought on market
- None
- Sold on market
- $10.5M
Companies where Pyott David E I is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 5,362 | $10.5M | $159.73 | Nov 12, 2026 | |||
| Directorsince February 2026 | 1,383 | $78.68 | Sep 17, 2026 | ||||
| Director | $0.6932 | Jun 10, 2025 | |||||
| Director | 49,750 | $57.99 | May 23, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 10, 2026ALNYDirector Pyott David E I exercised 3,780 shares at a strike of $71.99, increasing direct ownership by 239% to 5,362 unitsForm 4Exercise or conversion of a derivative
- Sep 15, 2026TARSDirector Pyott David E I converted options into 201 sharesForm 4Exercise or conversion of a derivative
- Jun 25, 2026TARSSEC Form 4 filed by Director Pyott David E IForm 4Grant or award
- Jun 1, 2026-$1.15MALNYDirector Pyott David E I sold $1,145,853 worth of shares (3,830 units at $299.18) as part of a pre-agreed trading plan and converted options into 3,830 sharesForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 1, 2026~$1.15MALNYPyott David E I plans to sell 3,830 shares (~$1.15M)Form 144Planned sale10b5-1 plan
- May 20, 2026ALNYDirector Pyott David E I was granted 671 shares, increasing direct ownership by 74% to 1,582 unitsForm 4Grant or award
- Apr 24, 2026TARSDirector Pyott David E I converted options into 1,383 sharesForm 4Exercise or conversion of a derivative
- Feb 18, 2026TARSSEC Form 4 filed by Director Pyott David E IForm 4Grant or award
- Feb 18, 2026TARSNew insider Pyott David E I claimed ownership of 7,991 sharesForm 3New insider
- Jun 5, 2025PLRXSEC Form 4 filed by Director Pyott David E IForm 4Grant or award
- May 8, 2025ALNYDirector Pyott David E I was granted 775 shares, increasing direct ownership by 570% to 911 unitsForm 4Grant or award
- Mar 24, 2025-$2.22MALNYDirector Pyott David E I exercised 7,440 shares at a strike of $88.95 and sold $2,224,560 worth of shares (7,440 units at $299.00)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 24, 2025~$2.22MALNYPyott David E I plans to sell 7,440 shares (~$2.22M)Form 144Planned sale10b5-1 plan
- Jun 24, 2024-$7.16MALNYDirector Pyott David E I exercised 32,450 shares at a strike of $80.76 and sold $7,161,360 worth of shares (32,450 units at $220.69)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 24, 2024~$7.16MALNYPyott David E I plans to sell 32,450 shares (~$7.16M)Form 144Planned sale10b5-1 plan
- Jun 13, 2024PLRXSEC Form 4 filed by Director Pyott David E IForm 4Grant or award
- May 21, 2024BMRNPyott David E I was granted 4,720 shares, increasing direct ownership by 10% to 49,750 unitsForm 4Grant or award
- May 16, 2024ALNYSEC Form 4 filed by Pyott David E IForm 4Grant or award
- Jun 7, 2023PLRXSEC Form 4 filed by Pyott David E IForm 4Grant or award
- May 23, 2023BMRNSEC Form 4 filed by Pyott David E IForm 4Grant or award
- May 18, 2023ALNYSEC Form 4 filed by Pyott David E IForm 4Grant or award
- Feb 23, 2023ALNYSEC Form 4: Pyott David E I converted options into 136 sharesForm 4Exercise or conversion of a derivative
- Jun 16, 2022PLRXSEC Form 4 filed by Pyott David E IForm 4Grant or award
- May 24, 2022BMRNSEC Form 4: Pyott David E I was granted 4,980 shares, increasing direct ownership by 14% to 40,840 unitsForm 4Grant or award
- May 18, 2022ALNYSEC Form 4 filed by Pyott David E IForm 4Grant or award
- Feb 23, 2022ALNYSEC Form 4 filed by Pyott David E IForm 4Grant or award
- Jul 15, 2021ALNYSEC Form 4 filed by PYOTT DAVID E IForm 4Grant or award
- Jun 29, 2021PLRXSEC Form 4 filed by PYOTT DAVID E I (Amendment)Form 4Grant or award
Compare Pyott David E I with
- Pyott David E I vs Charles Elliott Sigal1 shared
- Pyott David E I vs Amy W Schulman1 shared
- Pyott David E I vs Neera Clase1 shared
- Pyott David E I vs David Raben1 shared
- Pyott David E I vs Gregory R Friberg1 shared
- Pyott David E I vs Yvonne Greenstreet1 shared
Other insiders at the same companies
- Yvonne GreenstreetALNY
- Charles Elliott SigalALNY
- Amy W SchulmanALNY
- Neera ClaseTARS
- David RabenPLRX
- Gregory R FribergBMRN
- Wendy L YarnoTARS
- Link William J PhdTARS
- Robert M PlengeBMRN
- Bobak R. AzamianTARS
- Seshadri NeervannanTARS
- Elizabeth Yeu LinTARS
- George Eric DavisBMRN
- Aziz MottiwalaTARS
- Robert IannonePLRX
- Flavia BorelliniPLRX
Questions about Pyott David E I
- What is Pyott David E I's role at Alnylam Pharmaceuticals, Inc.?
- Pyott David E I reports to the SEC as director at Alnylam Pharmaceuticals, Inc. (ALNY), according to the latest filing on November 12, 2026. Pyott David E I has also filed as director at Tarsus Pharmaceuticals, Inc. (TARS), director at Pliant Therapeutics, Inc. (PLRX) and director at Biomarin Pharmaceutical Inc (BMRN).
- How many shares does Pyott David E I own?
- After the latest filing that states it, Pyott David E I directly owned 5,362 shares of Alnylam Pharmaceuticals, Inc. (ALNY), 1,383 shares of Tarsus Pharmaceuticals, Inc. (TARS) and 49,750 shares of Biomarin Pharmaceutical Inc (BMRN). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Pyott David E I bought or sold stock recently?
- The most recent open-market sale was on June 1, 2026: sold 3,830 shares of Alnylam Pharmaceuticals, Inc. (ALNY) for $1.15M at an average of $299.18.
- How do I get alerts when Pyott David E I files?
- Follow Pyott David E I on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Pyott David E I filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Pyott David E I (SEC CIK 0001051578). Totals count each trade once, skipping amendments whose original is on file, from Jul 2, 2021 on. View on SEC EDGAR